[Histonet] Validation of Her2

[Jesus Ellin]

What did you do to evaluate your system and algorithms.   Also the cases of ER and PR. Negative vs Postive concordance. 

Sent from my iPad

On Mar 19, 2013, at 4:57 PM, "Vickroy, Jim" <Vickroy.Jim <@t> mhsil.com> wrote:

> 
> We are working on validating HER 2 testing in our laboratory.  I see that the guidelines state that we should use 25 - 100 cases to complete our validation.
> In the past we sent our Her2 IHC testing to Clarient and they performed the technical testing and then our pathologists would do the scoring.  So for validation we used 25 of the cases we sent to Clarient and then did them in house to compare.   Our comparison was nearly 100%.  Here is my question:
> 
> Clarient uses the DAKO method while we are using Ventana's antibody Pathway (4B5).   The validation guidelines state "parallel by identical method in another lab with the same validated assay is also acceptable".  Can I assume that this means comparison with another lab for IHC HER2 testing and does not have to be using the same clone (DAKO vs Ventana)?
> 
> Jim
> 
> James Vickroy BS, HT(ASCP)
> 
> Surgical  and Autopsy Pathology Technical Supervisor
> Memorial Medical Center
> 217-788-4046
> 
> 
> ________________________________
> This message (including any attachments) contains confidential information intended for a specific individual and purpose, and is protected by law. If you are not the intended recipient, you should delete this message. Any disclosure, copying, or distribution of this message, or the taking of any action based on it, is strictly prohibited.
> _______________________________________________
> Histonet mailing list
> Histonet <@t> lists.utsouthwestern.edu
> http://lists.utsouthwestern.edu/mailman/listinfo/histonet

______________________________________________________________________
This message is confidential, intended only for the named 
recipient(s) and may contain information that is privileged 
or exempt from disclosure under applicable law.  If you are 
not the intended recipient(s), you are notified that the 
dissemination, distribution, or copying of this message is 
strictly prohibited.  If you receive this message in error, 
or are not the named recipient(s), please notify the sender 
at either the e-mail, fax, address, or telephone number 
listed above and delete this e-mail from your computer. 
Thank You.
______________________________________________________________________